-+ 0.00%
-+ 0.00%
-+ 0.00%

GENENTECH - ADVANCING ENICEPATIDE WITH PHASE III STUDIES AND PLANS FOR PHASE III TRIALS IN 2027

Reuters·09/22/2026 05:05:00

Please log in to view news